# Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma

> **NCT05914935** · EARLY_PHASE1 · UNKNOWN · sponsor: **Binhai Hospital of Fujian Medical University** · enrollment: 6 (estimated)

## Conditions studied

- Recurring Glioblastoma

## Interventions

- **DRUG:** Recombinant L-IFN adenovirus injection

## Key facts

- **NCT ID:** NCT05914935
- **Lead sponsor:** Binhai Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-27
- **Primary completion:** 2024-06-12
- **Final completion:** 2024-12-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05914935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05914935, "Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05914935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*